CCAL
CPRX

City Center Advisors LLC’s Catalyst Pharmaceutical CPRX Stock Holding History

City Center Advisors LLC’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,664
Closed -$338K – 175
2026
Q1 		$338K Sell
13,664
-1,111
-8% -$26.5K 0.31% 103
2025
Q4 		$345K Buy
14,775
+1,897
+15% +$42.3K 0.32% 99
2025
Q3 		$254K Buy
+12,878
New +$265K 0.25% 127

Other funds holding CPRX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
LTAS
Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
OLA
Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

City Center Advisors LLC's CPRX Position: Q2 2026 in Review

City Center Advisors LLC sold out of Catalyst Pharmaceutical (CPRX) in Q2 2026, closing a stake of 13,664 shares — an estimated $338K sold.

City Center Advisors LLC first reported a position in CPRX in Q3 2025 and held it in 3 quarters. The position peaked at $345K in Q4 2025. 36 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • City Center Advisors LLC reported no remaining Catalyst Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • City Center Advisors LLC sold 13,664 Catalyst Pharmaceutical shares in Q2 2026, an estimated $338K.
  • City Center Advisors LLC first reported a position in Catalyst Pharmaceutical in Q3 2025 and held it in 3 quarters.
  • City Center Advisors LLC's Catalyst Pharmaceutical position peaked at $345K in Q4 2025.
  • 36 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on City Center Advisors LLC's 13F filing for Q2 2026, filed 7 Jul 2026.